Hormonal & EndocrineResearch OnlyS

Kisspeptin

Kisspeptin-10

Neuropeptide signaling regulator of the GnRH axis, studied for reproductive endocrinology.

XRedditFacebook
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
Studies cited
3
Research grade
S
Community score
75

Trend index

Trackers
1,364

Overview

About Kisspeptin

Neuropeptide signaling regulator of the GnRH axis, studied for reproductive endocrinology.

Category
Hormonal & Endocrine
Regulatory status
Research Only
Also known as
Kisspeptin-10
Self-reports
29

Community

What 29 users report

29 community reports

Positive 3% · Neutral 4% · Negative 93%

Most reported benefits

Libido
150

Dose distribution

Median: 200–400 mcg · Most common: 200–400 mcg

0–25
0
25–50
0
50–100
0
100–200
46
200–400
102
400–600
1
600–1000
1
1000–2000
0
2000+
0

How repeat users are trending

Among repeat reporters, 78% said they felt similar to their last entry, 22% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 160 days · Based on 23 repeat reporters

Research

Cited research (2)

Help

Frequently asked

What do PeptIQ users report about Kisspeptin?

This page summarizes 29 anonymized self-reports from PeptIQ users who track Kisspeptin, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.

What research is cited for Kisspeptin?

2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.

Is Kisspeptin safe to use?

This wiki does not assess safety or recommend use. Kisspeptin is listed as Research Only. Consult a licensed clinician for personal medical decisions.

What are the purported benefits and uses of Kisspeptin?

Research, primarily in animal models, suggests Kisspeptin may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.

Source

What is the legal status of Kisspeptin?

Kisspeptin is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified Kisspeptin as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.

Source

What are the known or theoretical side effects and risks of Kisspeptin?

The safety and effectiveness of Kisspeptin have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.

Source

What is the current state of research on Kisspeptin?

While there are over 200 published studies on Kisspeptin, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.

Source